πŸ‡ΊπŸ‡Έ FDA
Patent

US 12428408

Fused heterocyclic mescaline derivatives

granted A61PA61P25/00

Quick answer

US patent 12428408 (Fused heterocyclic mescaline derivatives) held by Enveric Biosciences Canada Inc. expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enveric Biosciences Canada Inc.
Grant date
Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P25/00